Free Trial
NASDAQ:CRMD

CorMedix Q2 2025 Earnings Report

CorMedix logo
$10.33 -0.48 (-4.44%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$10.36 +0.03 (+0.29%)
As of 08/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CorMedix EPS Results

Actual EPS
$0.28
Consensus EPS
$0.20
Beat/Miss
Beat by +$0.08
One Year Ago EPS
-$0.25

CorMedix Revenue Results

Actual Revenue
$39.74 million
Expected Revenue
$29.88 million
Beat/Miss
Beat by +$9.86 million
YoY Revenue Growth
+4,830.10%

CorMedix Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 7, 2025
Conference Call Time
7:30AM ET

Upcoming Earnings

CorMedix's Q3 2025 earnings is scheduled for Wednesday, August 13, 2025

CorMedix Earnings Headlines

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
See More CorMedix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CorMedix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CorMedix and other key companies, straight to your email.

About CorMedix

CorMedix (NASDAQ:CRMD)., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

View CorMedix Profile

More Earnings Resources from MarketBeat